BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 337391)

  • 1. [Amines in mental disorders (author's transl)].
    Takahashi R
    Tanpakushitsu Kakusan Koso; 1977; 22(6):815-21. PubMed ID: 337391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 3. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical aspects of human behaviour (author's transl)].
    Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 7. [The significance of biogenic amines in cerebral infarction (author's transl)].
    Jellinger K; Riederer P; Kothbauer P
    Wien Klin Wochenschr; 1979 May; 91(10):339-44. PubMed ID: 452604
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of serum from acute schizophrenic patients on rabbit brain amines.
    Ancill RJ; Harston SJ; Neubauer H; Redfern PH
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):255-60. PubMed ID: 5523275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biogenic amines and aging (author's transl)].
    Muramoto O; Ando K
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1760-4. PubMed ID: 6117926
    [No Abstract]   [Full Text] [Related]  

  • 10. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical approaches to mental diseases].
    Henry MP
    Bord Med; 1972 Mar; 5(5):455-69. PubMed ID: 5071670
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of biogenic amines in certain pathological conditions.
    Subrahmanyam S
    Brain Res; 1975 Apr; 87(2-3):355-62. PubMed ID: 1125783
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavioral disorders: possible correlation with biogenic cerebral amines].
    Palermo Neto J; Carvalho FV
    Rev Paul Med; 1974 Mar; 83(3):137-44. PubMed ID: 4614362
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoamines (3): postmortem studies on the human brain in a suicide group].
    Gottfries CG; Winblad B
    Lakartidningen; 1978 Feb; 75(8):663-5. PubMed ID: 634000
    [No Abstract]   [Full Text] [Related]  

  • 17. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurochemistry and clinical psychiatry (author's transl)].
    Gross G
    Fortschr Neurol Psychiatr; 1981 Jan; 49(1):34-42. PubMed ID: 6971791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biogenic amines and effective disorders (author's transl)].
    Takahashi R
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1798-808. PubMed ID: 6171015
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains.
    Chmielewska B
    Pharmazie; 1984 Apr; 39(4):259-62. PubMed ID: 6204346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.